These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
595 related items for PubMed ID: 24048201
21. Use of beta-blockers in patients with an implantable cardioverter defibrillator. LaPointe NM, Stafford JA, Pappas PA, Al-Khatib SM, Anstrom KJ. Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655 [Abstract] [Full Text] [Related]
22. Deactivation of implantable cardioverter-defibrillators: results of patient surveys. Herman D, Stros P, Curila K, Kebza V, Osmancik P. Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573 [Abstract] [Full Text] [Related]
23. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S. Circulation; 2008 Apr 15; 117(15):1918-26. PubMed ID: 18391108 [Abstract] [Full Text] [Related]
24. Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score. Kraaier K, Scholten MF, Tijssen JG, Theuns DA, Jordaens LJ, Wilde AA, van Dessel PF. Europace; 2014 Jan 15; 16(1):40-6. PubMed ID: 23918791 [Abstract] [Full Text] [Related]
25. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior]. Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE. Z Kardiol; 2000 Jan 15; 89 Suppl 3():194-205. PubMed ID: 10810803 [Abstract] [Full Text] [Related]
26. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease. Martinelli M, de Siqueira SF, Sternick EB, Rassi A, Costa R, Ramires JA, Kalil Filho R. Am J Cardiol; 2012 Oct 01; 110(7):1040-5. PubMed ID: 22727179 [Abstract] [Full Text] [Related]
32. Sudden cardiac arrest and sudden cardiac death on dialysis: Epidemiology, evaluation, treatment, and prevention. Alpert MA. Hemodial Int; 2011 Oct 01; 15 Suppl 1():S22-9. PubMed ID: 22093597 [Abstract] [Full Text] [Related]
33. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria? Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA, NCDR. Am Heart J; 2009 Aug 01; 158(2):224-9. PubMed ID: 19619698 [Abstract] [Full Text] [Related]
34. Use of implantable cardioverter defibrillators in the New Zealand context from 2000 to 2007. Larsen PD, De Silva P, Harding SA, Woodcock E, Lever NA. N Z Med J; 2010 Feb 19; 123(1309):76-85. PubMed ID: 20186244 [Abstract] [Full Text] [Related]